Special Report
-
Narayanan Vaghul: The Corporate Philanthropy Catalyst
For Narayanan Vaghul, giving back to society is, quite simply, a human duty
-
The Road Ahead for Virendra Mhaiskar and IRB India
Virendra Mhaiskar has made IRB India’s largest and most profitable toll-road operator. In a sector that has most companies reeling under debt, he seems to be the rare animal with enough cash on hand
-
The Murugappas: Distinguished Philanthropic Family
Five generations of the Murugappa family have sworn by the Chettiar tradition of giving back to the community
-
London: Second Home for India's Wealthy
With its palatial mansions, high-end stores, designer outlets, restaurants, and hotels, London is a Mecca for wealthy Indians. Here, ultra high net-worth individuals can create what one marketer calls “cocoons of luxury, pastures of isolation, the unbranded, branded experience”. Here’s why:
-
Tata Trusts: Outstanding Corporate Foundation
The Tata Trusts are on the threshold of yet another evolutionary phase with Ratan Tata expected to channel his energy and vision into them
-
The Forbes 400 Summit of Leading Philanthropists
In June, Forbes convened the greatest-ever gathering of philanthropists: 161 billionaires or near-billionaires intent on solving the world’s most intractable problems. Six legends—Warren Buffett, Bill and Melinda Gates, Steve Case, David Rubenstein and Leon Black, who have collectively committed more than $100 billion of personal wealth—sat down to debate the highs and lows of giving back
-
India's Rich are Tasteful Art Collectors Too
India’s rich are no longer indifferent to art
-
The Power of Catalytic Philanthropy
Catalytic philanthropy has the high-stakes feel of the private market but can transcend the key market limitations
-
Warren Buffett’s Philanthropic Hero
Abraham Flexner probably influenced hilanthropy as much as any individual in the country
-
Emami Promoters Are Friends in Deed
In the minds of RS Agarwal and RS Goenka, the troubles of the past year have only reinforced the need to stick together
-
Dilip Shanghvi's Sun Pharma Enters the Next Phase of Growth
Dilip Shanghvi built Sun Pharma into one of the most profitable generic drugs companies in the world. Now, he’s stepped back and brought in Israel Makov to steer Sun into its next growth phase